Dibenzazepine, a γ-Secretase Enzyme Inhibitor, Protects Against Doxorubicin-Induced Cardiotoxicity by Suppressing NF-κB, iNOS, and Hes1/Hey1 Expression-Reference-Cited by-同舟云学术

Dibenzazepine, a γ-Secretase Enzyme Inhibitor, Protects Against Doxorubicin-Induced Cardiotoxicity by Suppressing NF-κB, iNOS, and Hes1/Hey1 Expression

Published:2024-07-30 Issue: Volume: Page:
ISSN:0360-3997
Container-title:Inflammation
language:en
Short-container-title:Inflammation

Author:

Badr Amira M.,Alotaibi Hind N.,El-Orabi Naglaa

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10753-024-02046-x.pdf

Reference89 articles.

1. Linders, A.N., I.B. Dias, T.L. Fernández, C.G. Tocchetti, N. Bomer, and P. Van der Meer. 2024. A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. NPJ Aging 10: 9. https://doi.org/10.1038/s41514-024-00135-7.

2. Thorn, C.F., C. Oshiro, S. Marsh, T. Hernandez-Boussard, H. McLeod, T.E. Klein, and R.B. Altman. 2011. Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenetics and Genomics 21: 440–446. https://doi.org/10.1097/FPC.0b013e32833ffb56.

3. Jasim, S.T., H.M. Al-Kuraishy, and A.I. Al-Gareeb. 2019. Gingko Biloba protects cardiomyocytes against acute doxorubicin induced cardiotoxicity by suppressing oxidative stress. JPMA. The Journal of the Pakistan Medical Association 69 (3): S103–S107.

4. Ikeda, So., S. Matsushima, K. Okabe, M. Ikeda, A. Ishikita, T. Tadokoro, N. Enzan, et al. 2019. Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway. Scientific Reports 9: 9850. https://doi.org/10.1038/s41598-019-46367-6.

5. Luu, A.Z., B. Chowdhury, M. Al-Omran, H. Teoh, D.A. Hess, and S. Verma. 2018. Role of endothelium in doxorubicin-induced cardiomyopathy. JACC. Basic to Translational Science 3: 861–870. https://doi.org/10.1016/j.jacbts.2018.06.005.